Who Paid My Doc
Acp-103-034
ClinicalTrials.gov NCT00550238
Research payments
$541,266
Through program year 2020, $541,266 in research payments was reported against Acp-103-034, across 724 payments, paid by ACADIA Pharmaceuticals Inc.
- Paid by
- ACADIA Pharmaceuticals Inc
- ClinicalTrials.gov
- NCT00550238
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $310,338 | 547 |
| 2019 | Research | $230,928 | 177 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Diane Highum Costa Mesa, CA Named on 92 payments
- Robert Riesenberg Atlanta, GA Named on 84 payments
- Steven Potkin Orange, CA Named on 75 payments
- Evagelos Coskinas Costa Mesa, CA Named on 67 payments
- Fayz Hudefi Barling, AR Named on 65 payments
- Rishi Kakar Tamarac, FL Named on 44 payments
- Constantin Abuzatoaie Hoffman Estates, IL Named on 43 payments
- Otto Dueno Dayton, OH Named on 40 payments
- Jeffrey Rado Chicago, IL Named on 39 payments
- Scott Bartley Dallas, TX Named on 29 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.